Literature DB >> 5266560

Leukocyte function in patients with leukemia.

F Rosner, I Valmont, P J Kozinn, L Caroline.   

Abstract

Entities:  

Mesh:

Year:  1970        PMID: 5266560     DOI: 10.1002/1097-0142(197004)25:4<835::aid-cncr2820250412>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  [Granulocyte dysfunction. Part II. Secondary defects. (authors transl)].

Authors:  D Niethammer; A Wildfeuer; E Kleihauer; O Haferkamp
Journal:  Klin Wochenschr       Date:  1975-08-15

2.  A physiological basis for the development of opportunistic infections in man.

Authors:  J W Alexander; J L Meakins
Journal:  Ann Surg       Date:  1972-09       Impact factor: 12.969

3.  Superoxide production of polymorphonuclear leukocytes in surgical patients with gastric cancer.

Authors:  T Nakagoe; S Watabe; M Tomita; A Tomonaga; T Kitamura
Journal:  Gastroenterol Jpn       Date:  1986-04

4.  Ascorbate and phagocyte function.

Authors:  L Stankova; N B Gerhardt; L Nagel; R H Bigley
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

5.  Neutrophil function in gram-negative rod bacteremia. The interaction between phagocytic cells, infecting organisms, and humoral factors.

Authors:  R J Weinstein; L S Young
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

6.  Differential endocytosis of fluorescein iso-thiocyanate-concanavalin A by normal and chronic myeloid leukemic granulocytes.

Authors:  S M Zingde; P N Anklesaria; S H Advani; A N Bhisey; B P Gothoskar
Journal:  Blut       Date:  1987-08

7.  A new neutrophil candida killing test: chromium-51 release from Candida guilliermondii.

Authors:  S Martin; A T Ghoneim; J A Child
Journal:  J Clin Pathol       Date:  1980-08       Impact factor: 3.411

8.  Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.

Authors:  I A Bakker-Woudenberg; J Y de Jong-Hoenderop; M F Michel
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.